(Q39405860)

11 September 2017

title

RSV entry inhibitors block F-protein mediated fusion with model membranes (English)

1 reference

11 September 2017

1 reference

Vladimir Razinkov

1

1 reference

11 September 2017

Clayton Huntley

series ordinal

2

1 reference

11 September 2017

George Ellestad

series ordinal

3

1 reference

11 September 2017

Girija Krishnamurthy

series ordinal

4

1 reference

11 September 2017

publication date

1 July 2002

1 reference

11 September 2017

1 reference

11 September 2017

volume

55

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

189-200

1 reference

Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Ribavirin therapy of adult respiratory syncytial virus pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Novel and specific respiratory syncytial virus inhibitors that target virus fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Respiratory syncytial virus infection in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Capture of an early fusion-active conformation of HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Fluorescence method for measuring the kinetics of fusion between biological membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

RFI-641, a potent respiratory syncytial virus inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Clinical profile of pediatric patients hospitalized with respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

The entry of enveloped viruses into cells by endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Infectious entry pathway of influenza virus in a canine kidney cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Membrane fusion by surrogate receptor-bound influenza haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Sterols and sphingolipids strongly affect the growth of fusion pores induced by the hemagglutinin of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

GPI-anchored proteins are organized in submicron domains at the cell surface.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Temperature dependence of fusion by sendai virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

Membrane fusion proteins of enveloped animal viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

The structure and function of the hemagglutinin membrane glycoprotein of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900050-5

7 January 2021

10.1016/S0166-3542(02)00050-5

Identifiers

DOI

1 reference

11 September 2017

1 reference